{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:06:30Z","timestamp":1781712390360,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81471165"],"award-info":[{"award-number":["81471165"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81670190"],"award-info":[{"award-number":["81670190"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670189"],"award-info":[{"award-number":["81670189"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870160"],"award-info":[{"award-number":["81870160"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971108"],"award-info":[{"award-number":["81971108"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of the Jilin Province","award":["20190201042JC"],"award-info":[{"award-number":["20190201042JC"]}]},{"name":"Natural Science Foundation of the Jilin Province","award":["20190201163JC"],"award-info":[{"award-number":["20190201163JC"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s00277-019-03800-0","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:02:19Z","timestamp":1588896139000},"page":"1331-1339","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pegfilgrastim improves the outcomes of mobilization and engraftment in autologous hematopoietic stem cell transplantation for the treatment of multiple myeloma"],"prefix":"10.1007","volume":"99","author":[{"given":"Xiao","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqiong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqiao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lugui","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehui","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2288-556X","authenticated-orcid":false,"given":"Fengyan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,8]]},"reference":[{"key":"3800_CR1","doi-asserted-by":"publisher","unstructured":"Duarte RF, Labopin M, Bade P et al Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019. Bone Marrow Transplant 2019. https:\/\/doi.org\/10.1038\/s41409-019-0516-20","DOI":"10.1038\/s41409-019-0516-20"},{"key":"3800_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1056\/NEJM199607113350204","volume":"335","author":"M Attal","year":"1996","unstructured":"Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF, Casassus P, Maisonneuve H, Facon T, Ifrah N, Payen C, Bataille R (1996) A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma: intergroupe francais du myeloma. N Engl J Med 335:91\u201397","journal-title":"N Engl J Med"},{"key":"3800_CR3","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1056\/NEJMoa022340","volume":"348","author":"JA Child","year":"2003","unstructured":"Child JA, Morgan GJ, Davies FE, Owen RG, Bell SE, Hawkins K, Brown J, Drayson MT, Selby PJ, Medical Research Council Adult Leukaemia Working Party (2003) High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 348:1875\u20131883","journal-title":"N Engl J Med"},{"key":"3800_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.bbmt.2006.09.010","volume":"13","author":"J Koreth","year":"2007","unstructured":"Koreth J, Cutler CS, Djulbegovic B, Behl R, Schlossman RL, Munshi NC, Richardson PG, Anderson KC, Soiffer RJ, Alyea EP III (2007) High-dose therapy with single autologous transplantation versus chemotherapy for newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials. Biol Blood Marrow Transpl 13:183\u2013196","journal-title":"Biol Blood Marrow Transpl"},{"key":"3800_CR5","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1182\/asheducation-2003.1.419","volume":"2003","author":"MH Cottler-Fox","year":"2003","unstructured":"Cottler-Fox MH, Lapidot T, Petit I et al (2003) Stem cell mobilization. Hematology Am Soc Hematol Educ Program 2003:419\u2013437","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"3800_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/bmt.2008.410","volume":"43","author":"W Bensinger","year":"2009","unstructured":"Bensinger W, DiPersio JF, MacCarty JM (2009) Improving stem cell mobilization strategies: future directions. Bone Marrow Transplant 43:181\u2013195","journal-title":"Bone Marrow Transplant"},{"key":"3800_CR7","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/bmt.2014.39","volume":"49","author":"Mohti","year":"2014","unstructured":"Mohti et al (2014) Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 49:865\u2013872","journal-title":"Bone Marrow Transplant"},{"key":"3800_CR8","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41409-017-0051-y","volume":"53","author":"J Olivieri","year":"2018","unstructured":"Olivieri J, Attolico I, Nuccorini R, Pascale SP, Chiarucci M, Poiani M, Corradini P, Farina L, Gaidano G, Nassi L, Sica S, Piccirillo N, Pioltelli PE, Martino M, Moscato T, Pini M, Zallio F, Ciceri F, Marktel S, Mengarelli A, Musto P, Capria S, Merli F, Codeluppi K, Mele G, Lanza F, Specchia G, Pastore D, Milone G, Saraceni F, di Nardo E, Perseghin P, Olivieri A (2018) Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) score. Bone Marrow Transplant 53:461\u2013473. https:\/\/doi.org\/10.1038\/s41409-017-0051-y","journal-title":"Bone Marrow Transplant"},{"key":"3800_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.bbmt.2013.10.013","volume":"20","author":"S Giralt","year":"2014","unstructured":"Giralt S, Costa L, Schriber J, DiPersio J, Maziarz R, McCarty J, Shaughnessy P, Snyder E, Bensinger W, Copelan E, Hosing C, Negrin R, Petersen FB, Rondelli D, Soiffer R, Leather H, Pazzalia A, Devine S (2014) Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations. Biol Blood Marrow Transplant. 20:295\u2013308","journal-title":"Biol Blood Marrow Transplant."},{"key":"3800_CR10","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1016\/S0301-472X(99)00112-5","volume":"27","author":"G Molineux","year":"1999","unstructured":"Molineux G, Kinstler O, Briddell B, Hartley C, McElroy P, Kerzic P, Sutherland W, Stoney G, Kern B, Fletcher FA, Cohen A, Korach E, Ulich T, McNiece I, Lockbaum P, Miller-Messana MA, Gardner S, Hunt T, Schwab G (1999) A new form of Filgrastim with sustained duration in vivo and enhanced ability to mobilize PBPC in both mice and humans. Exp Hematol 27:1724\u20131734","journal-title":"Exp Hematol"},{"key":"3800_CR11","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.2165\/00003495-200262080-00012","volume":"62","author":"MP Curran","year":"2002","unstructured":"Curran MP, Goa KL (2002) Pegfilgrastim. Drugs. 62:1207\u20131213","journal-title":"Drugs."},{"key":"3800_CR12","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/00001813-200304000-00002","volume":"14","author":"G Molineux","year":"2003","unstructured":"Molineux G (2003) Pegfilgrastim: using pegylation technology to improve neutropenia support in cancer patients. Anti-Cancer Drugs 14:259\u2013264","journal-title":"Anti-Cancer Drugs"},{"key":"3800_CR13","doi-asserted-by":"publisher","first-page":"9S","DOI":"10.1592\/phco.23.9.9S.32888","volume":"23","author":"WC Zamboni","year":"2003","unstructured":"Zamboni WC (2003) Pharmacokinetics of pegfilgrastim. Pharmacotherapy. 23:9S\u201314S","journal-title":"Pharmacotherapy."},{"key":"3800_CR14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2165\/11586040-000000000-00000","volume":"50","author":"BB Yang","year":"2011","unstructured":"Yang BB, Kido A (2011) Pharmacokinetics and pharmacodynamics of pegfilgrastim. Clin Pharmacokinet 50:295\u2013306","journal-title":"Clin Pharmacokinet"},{"key":"3800_CR15","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/bmt.2011.170","volume":"47","author":"SM Bakanay","year":"2012","unstructured":"Bakanay SM, Demirer T (2012) Novel agents and approaches for stem cell mobilization in normal donors and patients. Bone Marrow Transplant 47:1154\u20131163","journal-title":"Bone Marrow Transplant"},{"key":"3800_CR16","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1517\/14712598.2014.895809","volume":"14","author":"M Martino","year":"2014","unstructured":"Martino M, Laszlo D, Lanza F (2014) Long-active granulocyte colony-stimulating factor for peripheral blood hematopoietic progenitor cell mobilization. Expert Opin Biol Ther 14:757\u2013772","journal-title":"Expert Opin Biol Ther"},{"key":"3800_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1053\/j.seminoncol.2004.04.002","volume":"31","author":"L Biganzoli","year":"2004","unstructured":"Biganzoli L, Untch M, Skacel T, Pico JL (2004) Neulasta (pegfilgrastim): a once-per-cycle option for the management of chemotherapy-induced neutropenia. Semin Oncol 31:27\u201334","journal-title":"Semin Oncol"},{"key":"3800_CR18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S0093-7754(03)00314-2","volume":"30","author":"J Crawford","year":"2003","unstructured":"Crawford J (2003) Once-per-cycle pegfilgrastim (Neulasta) for the management of chemotherapy-induced neutropenia. Semin Oncol 30:24\u201330","journal-title":"Semin Oncol"},{"key":"3800_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/sj.bmt.1704702","volume":"35","author":"U Steidl","year":"2005","unstructured":"Steidl U, Fenk R, Bruns I, Neumann F, Kondakci M, Hoyer B, Gr\u00e4f T, Rohr UP, Bork S, Kronenwett R, Haas R, Kobbe G (2005) Successful transplantation of peripheral blood stem cells mobilized by chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma. Bone Marrow Transplant 35:33\u201336","journal-title":"Bone Marrow Transplant"},{"key":"3800_CR20","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1537-2995.2006.00699.x","volume":"46","author":"I Bruns","year":"2006","unstructured":"Bruns I, Steidl U, Kronenwett R, Fenk R, Graef T, Rohr UP, Neumann F, Fischer J, Scheid C, H\u00fcbel K, Haas R, Kobbe G (2006) A single dose of 6 or 12 mg of pegfilgrastim for peripheral blood progenitor cell mobilization results in similar yields of CD34+ progenitors in patients with multiple myeloma. Transfusion. 46:180\u2013185","journal-title":"Transfusion."},{"key":"3800_CR21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3324\/haematol.11287","volume":"93","author":"N Russell","year":"2008","unstructured":"Russell N, Mesters R, Schubert J, Boogaerts M, Johnsen HE, Canizo C, Baker N, Barker P, Skacel T, Schmitz N (2008) A phase 2 pilot study of pegfilgrastim and filgrastim for mobilizing peripheral blood progenitor cells in patients with non-Hodgkin\u2019s lymphoma receiving chemotherapy. Haematologica. 93:405\u2013412","journal-title":"Haematologica."},{"key":"3800_CR22","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00277-008-0675-5","volume":"88","author":"M Putkonen","year":"2009","unstructured":"Putkonen M, Rauhala A, Pelliniemi TT, Remes K (2009) Single-dose pegfilgrastim is comparable to daily filgrastim in mobilizing peripheral blood stem cells: a case-matched study in patients with lymphoproliferative malignancies. Ann Hematol 88:673\u2013680","journal-title":"Ann Hematol"},{"key":"3800_CR23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.transci.2010.10.001","volume":"43","author":"B Simona","year":"2010","unstructured":"Simona B, Cristina R, Luca N, Sara S, Aleksandra B, Paola B, Federica G, Pierluigi A, Laura O, Simona S, Jessica Q, Mara N, Giovanni M (2010) A single dose of pegfilgrastim versus daily filgrastim to evaluate the mobilization and the engraftment of autologous peripheral hematopoietic progenitors in malignant lymphoma patients candidate for high-dose chemotherapy. Transfus Apher Sci 43:321\u2013326","journal-title":"Transfus Apher Sci"},{"key":"3800_CR24","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.bbmt.2013.08.005","volume":"19","author":"F Lanza","year":"2013","unstructured":"Lanza F, Campioni DC, Hellmann A, Milone G, Wahlin A, Walewski J, Spedini P, Fiamenghi C, Cuneo A, Knopi\u0144ska W, Swierkowska-Czeneszew M, Petriz J, Fruehauf S, Farge D, Mohty M, Passweg J, Ruuto T, Madrigal A, Johnsen HE, Quality Assessment of Haematopoietic Stem Cell Grafting Committee of European Blood and Marrow Transplantation Society (2013) Individual quality assessment of autografting by probability estimation for clinical endpoints: a prospective validation study from the European Group for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 19:1670\u20131676","journal-title":"Biol Blood Marrow Transplant."},{"key":"3800_CR25","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","volume":"20","author":"BG Durie","year":"2006","unstructured":"Durie BG, Harousseau JL, Miguel JS et al (2006) International uniform response criteria for multiple myeloma. Leukemia. 20:1467\u20131473","journal-title":"Leukemia."},{"key":"3800_CR26","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","volume":"17","author":"S Kumar","year":"2016","unstructured":"Kumar S, Paiva B2, Anderson KC et al (2016) International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol 17:e328\u2013e346","journal-title":"Lancet Oncol"},{"key":"3800_CR27","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae). Multiple Myeloma (Version 1.2015). http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/myeloma.pdf. Accessed 25 Aug 2014"},{"key":"3800_CR28","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.ejca.2011.12.016","volume":"48","author":"C Sebban","year":"2012","unstructured":"Sebban C, Lefranc A, Perrier L, Moreau P, Espinouse D, Schmidt A, Kammoun L, Ghesquieres H, Ferlay C, Bay JO, Lissandre S, P\u00e9rol D, Michallet M, Quittet P (2012) A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study). Eur J Cancer 48:713\u2013720","journal-title":"Eur J Cancer"},{"key":"3800_CR29","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s40258-013-0011-7","volume":"11","author":"L Perrier","year":"2013","unstructured":"Perrier L, Lefranc A, P\u00e9rol D, Quittet P, Schmidt-Tanguy A, Siani C, de Peretti C, Favier B, Biron P, Moreau P, Bay JO, Lissandre S, Jardin F, Espinouse D, Sebban C (2013) Cost effectiveness of pegfilgrastim versus filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma: an economic evaluation of the PALM Trial. Appl Health Econ Health Policy 11:129\u2013138","journal-title":"Appl Health Econ Health Policy"},{"key":"3800_CR30","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/sj.bmt.1702514","volume":"26","author":"A Corso","year":"2000","unstructured":"Corso A, Caberlon S, Pagnucco G, Klersy C, Zappasodi P, Alessandrino EP, Vanelli L, Mangiacavalli S, Lazzarino M, Bernasconi C (2000) Blood stem cell collections in multiple myeloma: definition of a scoring system. Bone Marrow Transplant 26:283\u2013286","journal-title":"Bone Marrow Transplant"},{"key":"3800_CR31","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1038\/sj.bmt.1705166","volume":"36","author":"A Corso","year":"2005","unstructured":"Corso A, Mangiacavalli S, Nosari A et al (2005) Efficacy, toxicity and feasibility of a shorter schedule of DCEP regimen for stem cell mobilization in multiple myeloma. Bone Marrow Transplant 36:951\u2013954","journal-title":"Bone Marrow Transplant"},{"key":"3800_CR32","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/j.1537-2995.2007.01621.x","volume":"48","author":"P Zappasodi","year":"2008","unstructured":"Zappasodi P, Nosari AM, Astori C, Ciapanna D, Bonfichi M, Varettoni M, Mangiacavalli S, Morra E, Lazzarino M, Corso A (2008) DCEP chemotherapy followed by a single, fixed dose of pegylated filgrastim allows adequate stem cell mobilization in multiple myeloma patients. Transfusion. 48:857\u2013860","journal-title":"Transfusion."},{"key":"3800_CR33","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/bmt.2012.145","volume":"48","author":"KE Herbert","year":"2013","unstructured":"Herbert KE, Gambell P, Link EK, Mouminoglu A, Wall DM, Harrison SJ, Ritchie DS, Seymour JF, Prince HM (2013) Pegfilgrastim compared with filgrastim for cytokine-alone mobilization of autologous haematopoietic stem and progenitor cells. Bone Marrow Transplant 48:351\u2013356","journal-title":"Bone Marrow Transplant"},{"key":"3800_CR34","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/sj.bmt.1705675","volume":"39","author":"S Fruehauf","year":"2007","unstructured":"Fruehauf S, Klaus J, Huesing J, Veldwijk MR, Buss EC, Topaly J, Seeger T, Zeller LWJ, Moehler T, Ho AD, Goldschmidt H (2007) Efficient mobilization of peripheral blood stem cells following CAD chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma. Bone Marrow Transplant 39:743\u2013750","journal-title":"Bone Marrow Transplant"},{"key":"3800_CR35","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1038\/bmt.2009.373","volume":"45","author":"S Mathew","year":"2010","unstructured":"Mathew S, Adel N, Rice RD, Panageas K, Duck ET, Comenzo RL, Kewalramani T, Nimer SD (2010) Retrospective comparison of the effects of filgrastim and pegfilgrastim on the pace of engraftment in auto-SCT patients. Bone Marrow Transplant 45:1522\u20131527","journal-title":"Bone Marrow Transplant"},{"key":"3800_CR36","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1046\/j.1537-2995.1996.36796323059.x","volume":"36","author":"DF Stroncek","year":"1996","unstructured":"Stroncek DF, Clay ME, Petzoldt ML, Smith J, Jaszcz W, Oldham FB, McCullough J (1996) Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells. Transfusion. 36:601\u2013610","journal-title":"Transfusion."},{"key":"3800_CR37","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1111\/j.1537-2995.2012.03579.x","volume":"52","author":"LJ Costa","year":"2012","unstructured":"Costa LJ, Kramer C, Hogan KR, Butcher CD, Littleton AL, Shoptaw KB, Kang Y, Stuart RK (2012) Pegfilgrastim-versus filgrastim-based autologous hematopoietic stem cell mobilization in the setting of preemptive use of plerixafor: efficacy and cost analysis. Transfusion. 52:2375\u20132381","journal-title":"Transfusion."},{"key":"3800_CR38","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.bbmt.2018.09.005","volume":"25","author":"NL Watts","year":"2019","unstructured":"Watts NL, Marques MB, Peavey DB, Innis-Shelton R, Saad A, di Stasi A, Salzman D, Lamb LS Jr, Costa LJ (2019) Mobilization of hematopoietic progenitor cells for autologous transplantation using Pegfilgrastim and plerixafor: efficacy and cost implications. Biol Blood Marrow Transplant 25:233\u2013238","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03800-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-019-03800-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03800-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T23:37:23Z","timestamp":1620430643000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-019-03800-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,8]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["3800"],"URL":"https:\/\/doi.org\/10.1007\/s00277-019-03800-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,8]]},"assertion":[{"value":"29 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all patients for being included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}